Ashani Weeraratna
#70,890
Most Influential Person Now
American cancer researcher
Ashani Weeraratna's AcademicInfluence.com Rankings
Ashani Weeraratnalaw Degrees
Law
#3084
World Rank
#3872
Historical Rank
Common Law
#187
World Rank
#203
Historical Rank
International Law
#1161
World Rank
#1394
Historical Rank
Ashani Weeraratnabiology Degrees
Biology
#4602
World Rank
#6840
Historical Rank
Molecular Biology
#1229
World Rank
#1255
Historical Rank
Download Badge
Law Biology
Ashani Weeraratna's Degrees
- PhD Molecular Biology University of Pennsylvania
- Bachelors Biology University of Pennsylvania
Similar Degrees You Can Earn
Why Is Ashani Weeraratna Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ashani Tanuja Weeraratna is a Sri Lanka-born American cancer researcher whose findings are contributing to the scientific understanding of melanoma tumors. She is a Bloomberg Distinguished Professor of cancer biology and the E.V. McCollum Professor and Chair of the department of biochemistry and molecular biology at the Johns Hopkins Bloomberg School of Public Health. Weeraratna is a member of the National Cancer Advisory Board, which advises and assists the director of the National Cancer Institute on the activities of the national cancer program.
Ashani Weeraratna's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A framework for advancing our understanding of cancer-associated fibroblasts (2020) (1376)
- Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. (2002) (940)
- Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. (2017) (378)
- AGEMAP: A Gene Expression Database for Aging in Mice (2007) (377)
- The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* (2007) (355)
- Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. (2000) (309)
- Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. (2003) (307)
- How the ageing microenvironment influences tumour progression (2019) (295)
- sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance (2016) (251)
- Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. (2013) (202)
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations (2018) (196)
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. (2016) (195)
- The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma (2009) (193)
- Ghrelin promotes thymopoiesis during aging. (2007) (188)
- Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility. (2018) (182)
- Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. (2013) (171)
- Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility (2006) (161)
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma (2009) (158)
- PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion (2015) (151)
- Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR (2018) (141)
- Modeling the two-way feedback between contractility and matrix realignment reveals a nonlinear mode of cancer cell invasion (2017) (133)
- Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes (2006) (118)
- Thapsigargin induces a calmodulin/calcineurin‐dependent apoptotic cascade responsible for the death of prostatic cancer cells (2000) (118)
- Rational basis for Trk inhibition therapy for prostate cancer (2000) (116)
- Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. (2008) (115)
- Active Notch1 confers a transformed phenotype to primary human melanocytes. (2009) (110)
- Personalized Preclinical Trials in BRAF Inhibitor–Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies (2015) (103)
- PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells (2009) (103)
- Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells (2016) (102)
- Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. (2007) (96)
- Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching (2011) (93)
- A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma (2005) (92)
- Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells. (2001) (89)
- Faculty Opinions recommendation of Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. (2016) (89)
- Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells (2007) (87)
- Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt (2009) (85)
- The state of melanoma: challenges and opportunities (2016) (79)
- NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation (2009) (78)
- Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome (2004) (76)
- Wnt5A promotes an adaptive, senescent‐like stress response, while continuing to drive invasion in melanoma cells (2015) (76)
- Wnt5A activates the calpain-mediated cleavage of filamin A. (2009) (76)
- Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis. (2018) (73)
- Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration (2009) (73)
- Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility (2011) (73)
- A Wnt-er Migration: The Confusing Role of β-Catenin in Melanoma Metastasis (2013) (71)
- Ghrelin and the Growth Hormone Secretagogue Receptor Constitute a Novel Autocrine Pathway in Astrocytoma Motility* (2006) (70)
- Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells* (2009) (69)
- The Wnts of change: How Wnts regulate phenotype switching in melanoma. (2015) (68)
- Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma (2018) (65)
- Polyunsaturated Fatty Acids from Astrocytes Activate PPAR Gamma Signaling in Cancer Cells to Promote Brain Metastasis. (2019) (63)
- The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation (2012) (63)
- Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. (2009) (61)
- Gene Expression Profiling: From Microarrays to Medicine (2004) (56)
- RAF around the edges--the paradox of BRAF inhibitors. (2012) (53)
- Autophagy- An emerging target for melanoma therapy (2016) (53)
- In the Wnt-er of life: Wnt signalling in melanoma and ageing (2016) (52)
- Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. (2010) (50)
- Melanoma models for the next generation of therapies. (2021) (49)
- Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2. (2020) (48)
- The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report (2010) (43)
- Characterization of an endogenous RNA transcript with homology to the antisense strand of the human c-myc gene. (1992) (43)
- Novel Protein Kinase C-Mediated Control of Orai1 Function in Invasive Melanoma (2015) (42)
- Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. (2019) (39)
- Wnt signaling in human cancer. (2003) (38)
- CXCL12‐induced partitioning of flotillin‐1 with lipid rafts plays a role in CXCR4 function (2007) (37)
- Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility* (2013) (37)
- Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. (2009) (36)
- Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. (2017) (34)
- Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma. (2008) (31)
- Molecular signature and in vivo behavior of bone marrow endosteal and subendosteal stromal cell populations and their relevance to hematopoiesis. (2012) (31)
- Fat-Storing Multilocular Cells Expressing CCR5 Increase in the Thymus with Advancing Age: Potential Role for CCR5 Ligands on the Differentiation and Migration of Preadipocytes (2009) (31)
- Genetic screening for single-cell variability modulators driving therapy resistance (2019) (30)
- Bad company: Microenvironmentally mediated resistance to targeted therapy in melanoma (2018) (30)
- Stromal changes in the aged lung induce an emergence from melanoma dormancy (2020) (29)
- Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho (2017) (29)
- Transcriptome analysis of age-, gender- and diet-associated changes in murine thymus. (2007) (28)
- HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors. (2016) (27)
- When will melanoma vaccines be proven effective? (2004) (27)
- Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma (2012) (26)
- Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells (2006) (26)
- SAGE Identification and Fluorescence Imaging Analysis of Genes and Transcripts in Melanomas and Precursor Lesions (2004) (25)
- Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts. (2002) (24)
- p21 gene knock down does not identify genetic effectors seen with gene knock out (2007) (23)
- Transcriptome analysis of murine thymocytes reveals age-associated changes in thymic gene expression (2009) (23)
- Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells (2009) (22)
- ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma. (2017) (22)
- Loss of uteroglobin expression in prostate cancer: relationship to advancing grade. (1997) (21)
- Change is in the air: the hypoxic induction of phenotype switching in melanoma. (2013) (20)
- UV-induced Wnt7a in the human skin microenvironment specifies the fate of neural crest -like cells via suppression of Notch (2015) (19)
- Genetically‐defined ovarian cancer mouse models (2016) (19)
- Tumour Dormancy and Reawakening: Opportunities and Challenges. (2019) (19)
- The State of Melanoma: Emergent Challenges and Opportunities (2021) (18)
- Modulation of implantation-associated integrin expression but not uteroglobin by steroid hormones in an endometrial cell line. (1997) (18)
- Deconstructing tumor heterogeneity: the stromal perspective (2020) (18)
- Assaying Wnt5A-mediated invasion in melanoma cells. (2008) (17)
- Pre-determined diversity in resistant fates emerges from homogenous cells after anti-cancer drug treatment (2021) (17)
- Discovering causes and cures for cancer from gene expression analysis (2005) (16)
- Meeting report from the 7th International Melanoma Congress, Sydney, November, 2010 (2011) (14)
- Enhancing the evaluation of PI3K inhibitors through 3D melanoma models (2016) (13)
- ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4‐nerolidylcathecol (4‐NC) (2019) (13)
- Evaluating the impact of age on immune checkpoint therapy biomarkers (2021) (11)
- Serial analysis of gene expression (SAGE): advances, analysis and applications to pigment cell research. (2003) (11)
- Microarray data analysis: an overview of design, methodology, and analysis. (2007) (11)
- The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression. (2021) (11)
- Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer. (2002) (11)
- Shared genetic and epigenetic changes link aging and cancer. (2022) (11)
- sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients (2020) (10)
- Microarray Data Analysis (2007) (10)
- Automatic detection of melanoma progression by histological analysis of secondary sites (2012) (10)
- A spoonful of sugar makes the melanoma go: the role of heparan sulfate proteoglycans in melanoma metastasis (2011) (10)
- Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (2018) (9)
- Lack of Wnt5A expression in Merkel cell carcinoma. (2010) (8)
- Normal Aging and Its Role in Cancer Metastasis. (2020) (8)
- Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity (2020) (8)
- Bisphosphonamidate Clodronate Prodrug Exhibits Selective Cytotoxic Activity against Melanoma Cell Lines (2013) (8)
- Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma. (2020) (8)
- Women in cancer research (2019) (7)
- Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance (2016) (6)
- Disrupting cellular memory to overcome drug resistance (2022) (6)
- The APC tumor suppressor pathway. (2003) (6)
- A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis (2020) (5)
- Preserve junior faculty in biomedical sciences during and after the pandemic (2020) (5)
- Feedback between mechanosensitive signaling and active forces governs endothelial junction integrity (2022) (5)
- Erratum: Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma (Molecular Cell (2020) 77(3) (633–644.e5), (S109727651930838X), (10.1016/j.molcel.2019.11.009)) (2020) (3)
- The Race toward Equity: Increasing Racial Diversity in Cancer Research and Cancer Care. (2020) (3)
- clampFISH 2.0 enables rapid, scalable amplified RNA detection in situ (2022) (3)
- Novel PKC-mediated Control of Orai1 function in Invasive (2015) (3)
- Metastatic potential in clonal melanoma cells is driven by a rare, early-invading subpopulation (2023) (2)
- HSPG MODULATION OF WNT 5 A SIGNAL TRANSDUCTION IN METASTATIC MELANOMA CELLS (2009) (2)
- Faculty Opinions recommendation of Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K. (2011) (2)
- METABOLIC STRESS CONTROL OF CYTOSKELETAL DYNAMICS AND METASTASIS (2)
- Abstract A11: Crosstalk between klotho and wnt5A drives age-related melanoma progression (2015) (2)
- The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation (2012) (2)
- Evaluating the impact of age on immune checkpoint therapy biomarkers. (2021) (1)
- Faculty of 1000 evaluation for Combination cancer immunotherapy and new immunomodulatory targets. (2016) (1)
- A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities (2021) (1)
- Cover Picture: CXCL12-induced partitioning of flotillin-1 with lipid rafts plays a role in CXCR4 function – Eur. J. Immunol. 8/2007 (2007) (1)
- UNRelenting Translation UNRestrains Melanoma Migration. (2016) (1)
- Key Signaling Pathways in Normal and Neoplastic Melanocytes (2019) (1)
- HSP70 Inhibition Blocks Adaptive Resistance and Synergizes with MEK Inhibition for the Treatment of NRAS-Mutant Melanoma (2021) (1)
- A framework for advancing our understanding of cancer-associated fibroblasts (2020) (1)
- When metastasis ‘Spns’ out of control: Coverage of ‘Genome‐wide in vivo screen identifies novel host regulators of metastatic colonization’ (2017) (1)
- Meeting report from the 10th International Congress of the Society for Melanoma Research, Philadelphia, PA, November 2013 (2014) (1)
- Abstract A04: Aging microenvironment modulates melanoma invasion and metastasis (2015) (0)
- Abstract 2906: Role of autophagy in Wnt5A-mediated melanoma invasion and metastasis (2015) (0)
- Abstract 3642: The aged lung promotes reactivation from metastatic melanoma dormancy (2022) (0)
- Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis (2023) (0)
- 3 in a Murine Melanoma Syngeneic Model Requires 4 Costimulation, CD4, and CD8 T Cells (2016) (0)
- of CSF-1 R induced tumor infiltration by PMN-MDSC d Combination of CSF-1 R with CXCR 2 inhibitors demonstrated strong anti-tumor effect (2017) (0)
- Abstract IA013: Age-related changes in pancreatic fibroblasts drive pancreatic cancer growth and progression (2023) (0)
- Faculty Opinions recommendation of Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. (2012) (0)
- Cancer Therapy : Preclinical Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt 5 a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration (2009) (0)
- Fibroblasts in cancer: Unity in heterogeneity (2023) (0)
- Abstract IA023: Age against the machine: How the aging microenvironment drives tumor progression (2023) (0)
- How the ageing microenvironment influences tumour progression (2019) (0)
- Wnt5a regulates melanoma antigen recognized by T-cells-1 (MART-1), a predominant antigen in melanoma cells. (2006) (0)
- Novel targets in melanoma: stopping the signals that make tumors go (2007) (0)
- Genetic screening for single-cell variability modulators driving therapy resistance (2021) (0)
- Abstract 6107: Stromal and immune changes in the aged lung microenvironment create a permissive niche for the metastatic outgrowth of melanoma (2020) (0)
- Women in cancer research (2019) (0)
- Wnt5a regulates Mart1 expression via increases in IL-6 (2005) (0)
- Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research (2020) (0)
- Changing the culture for the future: time to take brain drain in academics seriously. (2022) (0)
- Abstract 1508: UV-induced Wnt7a in the human skin microenvironment specifies the fate of neural crest -like cells via suppression of Notch (2015) (0)
- Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (2018) (0)
- Abstract 2551: Sexual dimorphic effects of tumour microenvironment dictate melanoma progression and therapy resistance (2022) (0)
- Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma (2023) (0)
- Abstract 1566: Influence of age on fibroblast derived extracellular vesicles and their role in melanoma progression (2022) (0)
- Faculty Opinions recommendation of Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. (2008) (0)
- Abstract 1274: Extrinsic photoaging vs intrinsic aging in dermal fibroblasts: Its impact on the microenvironment and melanoma progression (2023) (0)
- Faculty Opinions recommendation of Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. (2008) (0)
- Abstract SY24-04: And by a sleep to say we end: Tumor dormancy, aging, and recurrent disease (2022) (0)
- Abstract 3775: p53 is differentially regulated in proliferative and invasive melanoma cells (2015) (0)
- 2 Response to Programmed Q 1 Cell Death-1 Blockade Q 2 3 in a Murine Melanoma Syngeneic Model Requires 4 Costimulation , CD 4 , and CD 8 T Cells 5 (2016) (0)
- Abstract 2346: Switching from an ROR1-positive phenotype to an ROR2-positive phenotype promotes melanoma progression (2011) (0)
- Abstract 4984: Association ofPTENandp16mutational status withMITFexpression may provide a novel context for a phenotype switch in melanoma (2011) (0)
- Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (2019) (0)
- A biphasic gene expression response to cisplatin treatment in ovarian cancer: An immediate early gene response followed by a p53 response (2006) (0)
- Faculty Opinions recommendation of Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP. (2013) (0)
- Abstract 3951: Age-dependent loss of HAPLN1 affects vascular integrity and metastasis in melanoma (2020) (0)
- Abstract IA014: The role of aging in reactivation from metastatic melanoma dormancy (2023) (0)
- Faculty Opinions recommendation of Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. (2012) (0)
- Abstract 4913: Invasive melanoma cells commandeer p53 activity to promote the survival of a therapy resistant subpopulation (2017) (0)
- Supporting women in science at PCMR (2019) (0)
- Abstract LB-213: Discovery and molecular modeling of a novel mutation in the vemurafenib binding site of BRAF associated with therapeutic resistance in a patient with metastatic melanoma (2014) (0)
- Advisory Board and Contents (2021) (0)
- Author Correction: Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis (2019) (0)
- Abstract B2: Effect of a changing microenvironment on the role of ROR receptors in melanoma progression (2011) (0)
- Abstract 3638: Age-related changes in pancreatic fibroblasts promote growth and progression of pancreatic cancer (2022) (0)
- Stromal changes in the aged lung induce an emergence from melanoma dormancy (2022) (0)
- Abstract 3996: Liquid to solid: Leukemic breast tumors assume the morphologic and genetic characteristics of breast cancer (2014) (0)
- Abstract 3637: Age-dependent loss of HAPLN1 erodes vascular integrity via upregulation of endothelial ICAM1 in melanoma (2022) (0)
- Abstract 71: Melanoma alters the bone marrow immune composition in an age-related manner (2023) (0)
- Melanoma Genomics—Techniques and Implications for Therapy (2008) (0)
- Gene Expression and Targeted Therapies— New Developments in Melanoma Treatment (2008) (0)
- P-196. Modulation of implantation-associated integrin but not uteroglobin expression by steroid hormones in an endometrial cell line (1997) (0)
- Abstract 1556: Role of Klotho in age-related melanoma progression (2015) (0)
- Abstract 993: Wnt-er is coming: WNT5A promotes a slow cycling phenotype via p53 in conditions of stress (2018) (0)
- Abstract 966: All stressed out: Phenoytpe plasticity and therapy resistance in melanoma (2022) (0)
- Abstract 5092: Midkine as a potential target for combating drug resistance and invasion in melanoma (2015) (0)
- Modeling the three-way feedback between cellular contractility, actin polymerization, and adhesion turnover resolves the contradictory effects of RhoA and Rac1 on endothelial junction dynamics (2021) (0)
- Small Molecule Therapeutics Bisphosphonamidate Clodronate Prodrug Exhibits Selective Cytotoxic Activity against Melanoma Cell Lines (2014) (0)
- Preserve junior faculty in biomedical sciences during and after the pandemic (2020) (0)
- Abstract 2554: Impact of the aged bone marrow on the anti-tumor response to melanoma (2022) (0)
- Abstract 2656: Myeloid derived Wnt5a influences the immune-dynamics of melanoma tumor microenvironment (2020) (0)
- Diversity, Equity, and Inclusion in the Melanoma Research Community (2022) (0)
- Faculty Opinions recommendation of Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. (2010) (0)
- Faculty Opinions recommendation of Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. (2016) (0)
- Aberrant Store-Operated Calcium Entry (SOCE) in Invasive Melanoma (2013) (0)
- Abstract 5086: The aged tumor microenvironment promotes melanoma metabolic plasticity and therapy (2020) (0)
- Discovering Merkel Cell Carcinoma Through Gene Expression Profiling (2010) (0)
- Abstract IA017: Age against the machine: How the aging tumor microenvironment governs tumor progression (2021) (0)
- Analysis of immune checkpoint blockade biomarkers in elderly patients using large-scale cancer genomics data. (2021) (0)
- Abstract B27: Wnt5A-expressing melanoma cells show classical markers of senescence following radiation and therapeutic stress, but retain the ability to metastasize and proliferate at distant sites (2015) (0)
- Abstract SY30-01: A wrinkle in TiME: How the aging TME drives tumor progression (2019) (0)
This paper list is powered by the following services:
Other Resources About Ashani Weeraratna
What Schools Are Affiliated With Ashani Weeraratna?
Ashani Weeraratna is affiliated with the following schools:
